Get the Stockscreener App
0.81
6.58%
0.05
After Hours:
.85
0.04
+4.94%
Aspira Womens Health Inc stock is traded at $0.81, with a volume of 208.91K.
It is up +6.58% in the last 24 hours and down -16.06% over the past month.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
See More
Previous Close:
$0.76
Open:
$0.7592
24h Volume:
208.91K
Relative Volume:
2.20
Market Cap:
$13.17M
Revenue:
$9.15M
Net Income/Loss:
$-16.18M
P/E Ratio:
-0.2786
EPS:
-2.907
Net Cash Flow:
$-15.92M
1W Performance:
+10.96%
1M Performance:
-16.06%
6M Performance:
-64.63%
1Y Performance:
-75.68%
1-Day Range:
$0.7592
$0.84
1-Week Range:
$0.6694
$0.84
52-Week Range:
$0.6679
$5.65
Aspira Womens Health Inc Stock (AWH) Company Profile
Name
Aspira Womens Health Inc
Sector
Industry
Phone
512-519-0400
Address
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN
Compare AWH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AWH
Aspira Womens Health Inc
|
0.81 | 13.17M | 9.15M | -16.18M | -15.92M | -2.907 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-29-21 | Initiated | Truist | Buy |
| Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-30-20 | Initiated | William Blair | Outperform |
Aspira Womens Health Inc Stock (AWH) Latest News
Aspira: Q3 Earnings Snapshot - New Haven Register
Aspira Women's Health Inc. (AWH) reports earnings - Quartz
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Call Transcript - Insider Monkey
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... - Yahoo Finance
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... By GuruFocus - Investing.com Canada
Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances - TipRanks
ARMISTICE CAPITAL, LLC Expands Stake in Aspira Womens Health Inc - GuruFocus.com
Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M - TipRanks
Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results - The Manila Times
Aspira Women's Health Q3: OvaWatch Grows 27%, Secures $10M Federal Contract | AWH Stock News - StockTitan
Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com - Defense World
Aspira Women?s Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch - Marketscreener.com
Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® - The Manila Times
Aspira Women's Health Expands BioReference Partnership, Reaches 15M+ Women With OvaWatch | AWH Stock News - StockTitan
StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 - StockTitan
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 - The Manila Times
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World
Aspira Women's Health updates product pipeline status By Investing.com - Investing.com South Africa
Aspira Women's Health updates product pipeline status - Investing.com India
Aspira Women’s Health Highlights Future Product Developments - TipRanks
AWH Stock Plummets 6.19% Amid Weak Financial Performance - GuruFocus.com
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - The Manila Times
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - The Manila Times
Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 - StockTitan
Aspira Women's Health secures $10M ARPA-H award - Investing.com India
Aspira Women's Health secures $10M ARPA-H award By Investing.com - Investing.com South Africa
Aspira Women's Health's SWOT analysis: stock faces growth hurdles amid diagnostic advances By Investing.com - Investing.com South Africa
FACT SHEET: Biden-Harris Administration Announces $110 Million in Awards from ARPA-H's Sprint for Women's Health to Accelerate New Discoveries and Innovation - The American Presidency Project
FemTech start-ups share in $110m Sprint for Women's Health - substack.com
Aspira Women's Health's SWOT analysis: stock faces growth hurdles amid diagnostic advances - Investing.com
HLTH24: Jill Biden announces $110M ARPA-H funding award, prods industry to invest in women's health - Fierce healthcare
Aspira Women's Health Inc. Announces Its Selection Receive $10 Million Award from Advanced Research Projects Agency for Health?s Sprint for Women's Health - Marketscreener.com
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health - The Manila Times
Innovative Food Holdings, Inc. Announces Fulfillment of Largest Purchase Order in the Company's History - The Manila Times
Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health - StockTitan
First Lady Dr. Jill Biden Announces $110 Million in Awards for Women's Health Research Push - The Washington Informer
Aspira Women's Health faces Nasdaq delisting over share price - Investing.com India
Aspira Women's Health faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
FDA's LDT RULE: Steps to Prepare for Your FDA 1st Milestone SubmissionDARKDaily.com - DARKDaily.com - Laboratory News
Aspira Women’s Health gets approval for OvaWatch ovarian cancer test - Medical Device Network
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch® - The Manila Times
Actelis Networks Announces Follow-On Order from U.S. Department of Transportation Agency Expanding Footprint to New Regions - The Manila Times
Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® - StockTitan
StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV) - Defense World
HOLX Launches BustTheMyth Campaign for Breast Health Awareness - Yahoo Finance
Analysts’ New Coverage for October 8th (ABT, ACLX, ALIM, AWH, BCAX, BCS, BIG, BTDR, CARV, CHEK) - Defense World
AWH Stock Plummets as Financial Data Reflects Losses - GuruFocus.com
Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges - GuruFocus.com
Aspira Womens Health Inc Stock (AWH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aspira Womens Health Inc Stock (AWH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cavanaugh Stefanie L. | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,938 |
0 |
60,914 |
| Parnell Winfred | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,156 |
0 |
55,740 |
| Herchuk Jannie Prestridge | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
8,438 |
0 |
57,190 |
| Ragard John Phillip | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
4,844 |
0 |
120,203 |
| Fralick Celeste Rachelle | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,000 |
0 |
45,665 |
| Sandford Nicole | Chief Executive Officer |
May 31 '24 |
Buy |
2.42 |
9,493 |
22,973 |
70,596 |
| Merchant Minh Hoang | Secretary & General Counsel |
Dec 06 '23 |
Sale |
3.37 |
980 |
3,303 |
0 |
| Sandford Nicole | President & CEO |
Dec 06 '23 |
Buy |
3.36 |
5,000 |
16,800 |
58,703 |
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):